Henry Schein, Inc. $HSIC is P2 Capital Partners LLC’s 8th Largest Position

P2 Capital Partners LLC cut its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 4.0% in the third quarter, Holdings Channel reports. The fund owned 361,786 shares of the company’s stock after selling 15,000 shares during the period. Henry Schein accounts for about 4.6% of P2 Capital Partners LLC’s portfolio, making the stock its 8th largest holding. P2 Capital Partners LLC’s holdings in Henry Schein were worth $24,012,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. CYBER HORNET ETFs LLC acquired a new position in shares of Henry Schein during the 2nd quarter valued at about $25,000. MUFG Securities EMEA plc acquired a new stake in Henry Schein during the second quarter worth about $27,000. Sentry Investment Management LLC raised its stake in Henry Schein by 132.1% during the third quarter. Sentry Investment Management LLC now owns 905 shares of the company’s stock worth $59,000 after purchasing an additional 515 shares during the period. Evelyn Partners Investment Management Services Ltd purchased a new position in Henry Schein during the second quarter worth about $62,000. Finally, Mather Group LLC. acquired a new position in Henry Schein in the 3rd quarter valued at about $71,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In other Henry Schein news, Director Kurt P. Kuehn sold 2,844 shares of the business’s stock in a transaction that occurred on Tuesday, March 10th. The stock was sold at an average price of $78.96, for a total value of $224,562.24. Following the sale, the director owned 15,420 shares of the company’s stock, valued at $1,217,563.20. The trade was a 15.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Philip A. Laskawy sold 2,844 shares of the company’s stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $80.36, for a total value of $228,543.84. Following the transaction, the director owned 21,961 shares in the company, valued at $1,764,785.96. This trade represents a 11.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 104,556 shares of company stock worth $8,476,351 over the last quarter. Company insiders own 1.08% of the company’s stock.

Analyst Upgrades and Downgrades

HSIC has been the subject of several analyst reports. Mizuho increased their price target on shares of Henry Schein from $81.00 to $88.00 and gave the company a “neutral” rating in a research note on Wednesday, February 25th. UBS Group lifted their price target on shares of Henry Schein from $79.00 to $87.00 and gave the company a “neutral” rating in a research report on Wednesday, February 25th. Wells Fargo & Company upped their price objective on Henry Schein from $76.00 to $87.00 and gave the company an “equal weight” rating in a report on Wednesday, February 25th. Leerink Partners reiterated a “market perform” rating on shares of Henry Schein in a research report on Monday. Finally, Wall Street Zen cut Henry Schein from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Six investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $85.58.

Henry Schein Trading Up 0.8%

Shares of HSIC stock opened at $75.57 on Friday. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $89.29. The firm has a market cap of $8.67 billion, a PE ratio of 23.11, a price-to-earnings-growth ratio of 2.22 and a beta of 0.88. The company has a 50-day moving average of $78.21 and a two-hundred day moving average of $72.83. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.38 and a quick ratio of 0.76.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 24th. The company reported $1.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.30 by $0.04. Henry Schein had a net margin of 3.02% and a return on equity of 15.16%. The business had revenue of $3.44 billion for the quarter, compared to the consensus estimate of $3.34 billion. During the same period in the previous year, the firm earned $1.19 EPS. The business’s revenue was up 7.7% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. On average, analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.